BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 35361871)

  • 21. Schisandrin B Attenuates Colitis-Associated Colorectal Cancer through SIRT1 Linked SMURF2 Signaling.
    Pu Z; Zhang W; Wang M; Xu M; Xie H; Zhao J
    Am J Chin Med; 2021; 49(7):1773-1789. PubMed ID: 34632965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E3 ubiquitin ligase SMURF2 prevents colorectal cancer by reducing the stability of the YY1 protein and inhibiting the SENP1/c-myc axis.
    Gao Q; Wang S; Zhang Z
    Gene Ther; 2023 Feb; 30(1-2):51-63. PubMed ID: 34545207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?
    Gires O; Pan M; Schinke H; Canis M; Baeuerle PA
    Cancer Metastasis Rev; 2020 Sep; 39(3):969-987. PubMed ID: 32507912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ubiquitination-mediated degradation of SIRT1 by SMURF2 suppresses CRC cell proliferation and tumorigenesis.
    Yu L; Dong L; Li H; Liu Z; Luo Z; Duan G; Dai X; Lin Z
    Oncogene; 2020 May; 39(22):4450-4464. PubMed ID: 32361710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High expression of Krüppel-like factor 5 is associated with poor prognosis in patients with colorectal cancer.
    Takagi Y; Sakai N; Yoshitomi H; Furukawa K; Takayashiki T; Kuboki S; Takano S; Suzuki D; Kagawa S; Mishima T; Nakadai E; Miyauchi H; Matsubara H; Ohtsuka M
    Cancer Sci; 2020 Jun; 111(6):2078-2092. PubMed ID: 32279400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ubiquitination ligase SMURF2 reduces aerobic glycolysis and colorectal cancer cell proliferation by promoting ChREBP ubiquitination and degradation.
    Li Y; Yang D; Tian N; Zhang P; Zhu Y; Meng J; Feng M; Lu Y; Liu Q; Tong L; Hu L; Zhang L; Yang JY; Wu L; Tong X
    J Biol Chem; 2019 Oct; 294(40):14745-14756. PubMed ID: 31409643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E3 ubiquitin ligase Smurf2: a prognostic factor in microsatellite stable colorectal cancer.
    Klupp F; Giese C; Halama N; Franz C; Lasitschka F; Warth A; Schmidt T; Kloor M; Ulrich A; Schneider M
    Cancer Manag Res; 2019; 11():1795-1803. PubMed ID: 30863185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
    Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
    CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal cancer liver metastases - a population-based study on incidence, management and survival.
    Engstrand J; Nilsson H; Strömberg C; Jonas E; Freedman J
    BMC Cancer; 2018 Jan; 18(1):78. PubMed ID: 29334918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated Resections of Hepatic and Pulmonary Metastases from Colorectal Cancer Provide Long-Term Survival.
    Bellier J; De Wolf J; Hebbar M; Amrani ME; Desauw C; Leteurtre E; Pruvot FR; Porte H; Truant S
    World J Surg; 2018 Apr; 42(4):1171-1179. PubMed ID: 28948336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does Repeated Lung Resection Provide Long-Term Survival for Recurrent Pulmonary Metastases of Colorectal Cancer? Results of a Retrospective Japanese Multicenter Study.
    Hishida T; Tsuboi M; Okumura T; Boku N; Ohde Y; Sakao Y; Yoshiya K; Hyodo I; Mori K; Kondo H
    Ann Thorac Surg; 2017 Feb; 103(2):399-405. PubMed ID: 27793399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predominant expression of truncated EpCAM is associated with a more aggressive phenotype and predicts poor overall survival in colorectal cancer.
    Seeber A; Untergasser G; Spizzo G; Terracciano L; Lugli A; Kasal A; Kocher F; Steiner N; Mazzoleni G; Gastl G; Fong D
    Int J Cancer; 2016 Aug; 139(3):657-63. PubMed ID: 26996277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ubiquitin ligase Smurf2 suppresses TGFβ-induced epithelial-mesenchymal transition in a sumoylation-regulated manner.
    Chandhoke AS; Karve K; Dadakhujaev S; Netherton S; Deng L; Bonni S
    Cell Death Differ; 2016 May; 23(5):876-88. PubMed ID: 26679521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic, molecular, and prognostic implications of the loss of EPCAM expression in colorectal carcinoma.
    Kim JH; Bae JM; Song YS; Cho NY; Lee HS; Kang GH
    Oncotarget; 2016 Mar; 7(12):13372-87. PubMed ID: 26528695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival benefit of repeat resection of successive recurrences after the initial hepatic resection for colorectal liver metastases.
    Oba M; Hasegawa K; Shindoh J; Yamashita S; Sakamoto Y; Makuuchi M; Kokudo N
    Surgery; 2016 Feb; 159(2):632-40. PubMed ID: 26477476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-15b promotes epithelial-mesenchymal transition by inhibiting SMURF2 in pancreatic cancer.
    Zhang WL; Zhang JH; Wu XZ; Yan T; Lv W
    Int J Oncol; 2015 Sep; 47(3):1043-53. PubMed ID: 26166038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma.
    Hackl C; Neumann P; Gerken M; Loss M; Klinkhammer-Schalke M; Schlitt HJ
    BMC Cancer; 2014 Nov; 14():810. PubMed ID: 25369977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smurf2 E3 ubiquitin ligase modulates proliferation and invasiveness of breast cancer cells in a CNKSR2 dependent manner.
    David D; Jagadeeshan S; Hariharan R; Nair AS; Pillai RM
    Cell Div; 2014; 9():2. PubMed ID: 25191523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer.
    Goossens-Beumer IJ; Zeestraten EC; Benard A; Christen T; Reimers MS; Keijzer R; Sier CF; Liefers GJ; Morreau H; Putter H; Vahrmeijer AL; van de Velde CJ; Kuppen PJ
    Br J Cancer; 2014 Jun; 110(12):2935-44. PubMed ID: 24786601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discrepancy between recurrence-free survival and overall survival in patients with resectable colorectal liver metastases: a potential surrogate endpoint for time to surgical failure.
    Oba M; Hasegawa K; Matsuyama Y; Shindoh J; Mise Y; Aoki T; Sakamoto Y; Sugawara Y; Makuuchi M; Kokudo N
    Ann Surg Oncol; 2014 Jun; 21(6):1817-24. PubMed ID: 24499828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.